• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

    6/5/24 5:27:25 AM ET
    $ANNX
    $ASNS
    $BGXX
    $CCM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $ANNX alert in real time by email

    Shares of Stitch Fix, Inc. (NASDAQ:SFIX) rose sharply in today's pre-market trading following better-than-expected third-quarter financial results.

    Stitch Fix reported quarterly losses of 18 cents per share which beat the analyst consensus estimate of losses of 24 cents by 25%. Quarterly sales came in at $322.7 million which beat the analyst consensus estimate of $306.121 million by 5.42% and represents a 18.29% decrease in sales from the same period last year, according to data from Benzinga Pro.

    Stitch Fix shares jumped 18% to $3.15 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Actelis Networks, Inc. (NASDAQ:ASNS) rose 794% to $4.20 in today's pre-market trading after the company announced orders for cyber-hardened networking technology to be deployed at three US military bases.
    • mF International Limited (NASDAQ:MFI) gained 108.4% to $2.71 in pre-market trading after jumping 38% on Tuesday.
    • ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares gained 79% to $0.1521 in pre-market trading. ENDRA Life Sciences shares dipped over 60% on Tuesday after the company announced the pricing of an $8 million public offering.
    • WalkMe Ltd.  (NASDAQ:WKME) gained 44% to $13.88 in pre-market trading. SAP entered into an agreement to acquire WalkMe.
    • Bright Green Corporation (NASDAQ:BGXX) shares rose 30.2% to $0.3841 in pre-market trading after gaining around 5% on Tuesday.
    • Concord Medical Services Holdings Limited (NYSE:CCM) rose 20% to $2.52 in pre-market trading after jumping 166% on Tuesday.
    • Jayud Global Logistics Limited (NASDAQ:JYD) gained 15% to $0.8213 in pre-market trading after falling 6% on Tuesday.
    • Hewlett Packard Enterprise Company (NYSE:HPE) shares rose 14.7% to $20.18 in pre-market trading as the company reported better-than-expected second-quarter financial results.
    • Mangoceuticals, Inc. (NASDAQ:MGRX) shares climbed 12.3% to $0.4459 in pre-market trading. Mangoceuticals recently announced the development of proprietary formulations of Enclomiphene Citrate, Pregnenolone and Dehydroepiandrosterone in an Oral Dissolvable Tablet for the treatment of low testosterone and male hormone imbalances.

    Losers

    • MicroAlgo Inc. (NASDAQ:MLGO) shares declined 30.1% to $8.40 in pre-market trading. MicoAlgo shares jumped around 670% on Tuesday after the company announced that it will jointly establish a micro-consciousness quantum research center with WiMi.
    • SOBR Safe, Inc. (NASDAQ:SOBR) shares declined 27% to $0.3360 in pre-market trading after surging 75% on Tuesday.
    • Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) shares dipped 18.7% to $0.1830 in pre-market trading after declining around 4% on Tuesday.
    • Fresh2 Group Limited (NASDAQ:FRES) shares fell 18.3% to $0.3646 in pre-market trading after gaining 13% on Tuesday.
    • COMPASS Pathways plc (NASDAQ:CMPS) shares fell 16.6% to $6.40 in pre-market trading.
    • Vast Renewables Limited (NASDAQ:VSTE) shares fell 15.4% to $3.80 in pre-market trading after jumping around 67% on Tuesday.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) shares fell 15.2% to $7.00 in pre-market trading after declining 5% on Tuesday.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares declined 14.7% to $0.5437 in pre-market trading after gaining over 10% on Tuesday.
    • Annexon, Inc. (NASDAQ:ANNX) shares fell 11.5% to $5.30 in pre-market trading after the company announced a proposed public offering of common stock.
    • Multi Ways Holdings Limited (NYSE:MWG) fell 9.8% to $0.4335 in pre-market trading after gaining around 31% on Tuesday.

    Now Read This: Fear & Greed Index In ‘Fear’ Zone; But Dow Gains Over 100 Points

    Get the next $ANNX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANNX
    $ASNS
    $BGXX
    $CCM

    CompanyDatePrice TargetRatingAnalyst
    Hewlett Packard Enterprise Company
    $HPE
    1/13/2026$31.00Buy
    Goldman
    Annexon Inc.
    $ANNX
    12/23/2025$16.00Buy
    Chardan Capital Markets
    COMPASS Pathways Plc
    $CMPS
    12/10/2025$15.00Perform → Outperform
    Oppenheimer
    Hewlett Packard Enterprise Company
    $HPE
    11/17/2025Overweight → Equal-Weight
    Morgan Stanley
    Hewlett Packard Enterprise Company
    $HPE
    10/22/2025$24.00Neutral
    Piper Sandler
    Mind Medicine (MindMed) Inc.
    $MNMD
    10/13/2025$28.00Buy
    Needham
    Hewlett Packard Enterprise Company
    $HPE
    9/16/2025$24.00Mkt Perform
    Bernstein
    Hewlett Packard Enterprise Company
    $HPE
    8/21/2025$28.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman resumed coverage on Hewlett Packard Enterprise with a new price target

    Goldman resumed coverage of Hewlett Packard Enterprise with a rating of Buy and set a new price target of $31.00

    1/13/26 9:16:01 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    Chardan Capital Markets initiated coverage on Annexon with a new price target

    Chardan Capital Markets initiated coverage of Annexon with a rating of Buy and set a new price target of $16.00

    12/23/25 8:41:58 AM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    COMPASS Pathways upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded COMPASS Pathways from Perform to Outperform and set a new price target of $15.00

    12/10/25 8:10:44 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders

    Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 26, 2026 /CNW/ -- USA News Group News Commentary – The first psilocybin compound to achieve two positive Phase 3 results in treatment-resistant depression cleared that milestone this week, signaling a potential shift in how regulators and investors view psychedelic-based psychiatry[1]. The pathway is widening at the federal level, where the Drug Enforcement Administration raised its 2026 psilocybin production quota by 67%[2]. Five companies are working to translate that momentum into approved treatments: Helus Pharma (NASDAQ:HELP), Compass Pathways (NASDAQ:CMPS), Relmada Therapeutics (NASDAQ:RLMD), Alto Neuroscience (NYSE:ANRO), and Axsome

    2/26/26 12:07:00 PM ET
    $ANRO
    $AXSM
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

    Achieved Intraclass Correlation Coefficient (ICC) of 0.89 with standard error of measurement (SEM) of 3.3% using independent operators ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced favorable results from a clinical study evaluating the measurement consistency of its TAEUS® Liver device. The study demonstrated the device's robust intra-user repeatability and inter-user reproducibility, essential factors for long-term monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), which now affects approximately 30% of ad

    2/26/26 8:00:00 AM ET
    $NDRA
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

    Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were issued on January 13, 2025, for proceeds of approximately $200 million. Upon exercise of these outstanding warrants, Compass Pathways is issuing 15,160,619 American Depositary Shares ("ADSs") and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 19,898,829 ADSs. Compass Pathways currently intends to use the proceeds from these warrant exercises, together with its existing cash and cash equivalents, to fund ongoing COMP005 and COMP006 Phase 3 trials, its Pha

    2/26/26 6:30:00 AM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carson William H. bought $20,657 worth of shares (4,115 units at $5.02), increasing direct ownership by 8% to 54,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    1/2/26 4:30:06 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Carson William H. bought $18,394 worth of shares (4,115 units at $4.47), increasing direct ownership by 9% to 50,290 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    12/3/25 4:30:14 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Choi Jung bought $138,270 worth of shares (33,000 units at $4.19) (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    12/3/25 4:30:20 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Pres GM Networking Rahim Rami exercised 177,858 shares at a strike of $21.37 and covered exercise/tax liability with 88,324 shares (SEC Form 4)

    4 - Hewlett Packard Enterprise Co (0001645590) (Issuer)

    2/24/26 4:29:47 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4 filed by PRESIDENT AND CEO Love Douglas

    4 - Annexon, Inc. (0001528115) (Issuer)

    2/23/26 7:11:22 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHIEF MEDICAL OFFICER Dananberg Jamie was granted 56,250 shares, increasing direct ownership by 77% to 129,402 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    2/23/26 7:09:58 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $ASNS
    $BGXX
    $CCM
    SEC Filings

    View All

    SEC Form S-8 filed by SOBR Safe Inc.

    S-8 - SOBR Safe, Inc. (0001425627) (Filer)

    2/27/26 5:14:59 PM ET
    $SOBR
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form 6-K filed by Golden Heaven Group Holdings Ltd.

    6-K - GOLDEN HEAVEN GROUP HOLDINGS LTD. (0001928340) (Filer)

    2/24/26 4:29:47 PM ET
    $GDHG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 6-K filed by Golden Heaven Group Holdings Ltd.

    6-K - GOLDEN HEAVEN GROUP HOLDINGS LTD. (0001928340) (Filer)

    2/23/26 4:15:01 PM ET
    $GDHG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Financials

    Live finance-specific insights

    View All

    Stitch Fix Announces Date for Second Quarter 2026 Financial Results and Conference Call

    Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its second quarter fiscal year 2026 ended January 31, 2026 after market close on Wednesday, March 11, 2026. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of the call will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. To access the call by phone, please register at this registration link. Upon registration, telephone particip

    2/18/26 4:05:00 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    HPE to Present Live Audio Webcast of Fiscal 2026 First Quarter Earnings Conference Call

    HPE (NYSE:HPE) will conduct a live audio webcast of a conference call with analysts to review financial results for the first quarter of fiscal 2026, ending January 31, 2026. The call is scheduled for Monday, March 9, at 4:00 p.m. CT (5:00 p.m. ET), and the webcast will be available at www.hpe.com/investor/2026Q1Webcast. A replay of the webcast will be available at the same website shortly after the call and will remain available for approximately one year. For additional information, see investors.hpe.com. About HPE HPE (NYSE:HPE) is a leader in essential enterprise technology, bringing together the power of AI, cloud, and networking to help organizations achieve more. As pioneers

    2/3/26 7:45:00 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    HPE Reports Fiscal 2025 Fourth Quarter Results

    Posts record quarterly revenue and gross profit; raises FY26 guidance HPE (NYSE:HPE) today announced financial results for the fourth quarter ended October 31, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204671507/en/ "HPE finished a transformative year with a strong fourth quarter of profitable growth and disciplined execution," said Antonio Neri, president and CEO of HPE. "During the year, we completed the Juniper Networks acquisition, further scaled our AI and Cloud businesses, and accelerated innovation across our portfolio, giving HPE momentum to advance our strategic priorities in fiscal 2026." "HPE continued

    12/4/25 4:05:00 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Leadership Updates

    Live Leadership Updates

    View All

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    mF International Announces Executive Transition as Company Launches Digital Asset Treasury Strategy

    HONG KONG, Nov. 25, 2025 /PRNewswire/ -- mF International Limited (NASDAQ:MFI) ("mF" or the "Company") announced today that Mr. Haoyu Wang has resigned from his position of CEO, director, and chief compliance officer ("CCO") of the Company effective November 24, 2025. Mr. Dawei Yuan, an entrepreneur with extensive experience in blockchain infrastructure development and security, has been appointed by the board of directors (the "Board") to succeed Mr. Wang as CEO of the Company, and has been appointed as an executive Director and Chairman of the Board of the Company, effective immediately. This strategic appointment comes at a pivotal moment as the Company establishes its recently announced

    11/25/25 7:30:00 AM ET
    $MFI
    EDP Services
    Technology

    HPE Appoints Phil Mottram to Lead Global Sales

    HPE veteran Heiko Meyer to retire after 38 years with the company HPE (NYSE:HPE) today named Phil Mottram as Executive Vice President and Chief Sales Officer, effective November 1, 2025. In this role, Mottram will lead HPE's global sales teams across the company's Servers and Hybrid Cloud solutions, as well as its channel and partner ecosystem. Mottram joined the company in 2019 and has held executive management roles including leading HPE's networking business for four years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916745439/en/HPE named Phil Mottram as Executive Vice President and Chief Sales Officer, effective Nov

    9/16/25 1:00:00 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ANNX
    $ASNS
    $BGXX
    $CCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Vast Renewables Limited

    SC 13D/A - Vast Renewables Ltd (0001964630) (Subject)

    12/16/24 8:59:53 PM ET
    $VSTE
    Building Products
    Industrials

    Amendment: SEC Form SC 13D/A filed by Vast Renewables Limited

    SC 13D/A - Vast Renewables Ltd (0001964630) (Subject)

    11/27/24 6:49:39 PM ET
    $VSTE
    Building Products
    Industrials

    Amendment: SEC Form SC 13D/A filed by Vast Renewables Limited

    SC 13D/A - Vast Renewables Ltd (0001964630) (Subject)

    11/25/24 9:02:15 AM ET
    $VSTE
    Building Products
    Industrials